• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 35 of 38
Leaving Corporate America for a Startup: The Best Decision I Ever Made
Startups & VentureLeaving Corporate America for a Startup: The Best Decision I Ever Made
By Sara PearyJanuary 13, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance2015 Is Now the Biggest Year Ever for M&A
By Chris MatthewsDecember 4, 2015
ECB President Mario Draghi Rates Conference
FinanceMarkets Fall On Draghi Misfire
By Alan MurrayDecember 4, 2015
Cindy Whitehead, chief executive officer of Sprout Pharmaceuticals Inc., speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, Aug. 19, 2015. Whitehead discussed Addyi, the company's pill for low libido in women that won approval from the U.S. Food and Drug Administration yesterday. Photographer: Chris Goodney/Bloomberg *** Local Caption *** Cindy Whitehead
MPWSprout’s CEO On Why We Should Stop Calling Addyi ‘the Female Viagra’
By Kia KokalitchevaDecember 1, 2015
Pfizer CEO Ian Read
FinancePfizer Says No Merger Tax Help For Our Top Execs
By Dan PrimackNovember 25, 2015
Pfizer CEO Ian Read
LeadershipPfizer’s CEO Isn’t a Hero or a Villain
By Geoff ColvinNovember 25, 2015
Why Washington is Tackling the Tax Inversion Problem All Wrong
LeadershipWhy Washington is Tackling the Tax Inversion Problem All Wrong
By Chris MatthewsNovember 25, 2015
Pfizer In Merger Talks With Allergan PLC
FinancePfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By Stephen GandelNovember 24, 2015
Pfizer In Merger Talks With Allergan PLC
FinanceInvestors Aren’t Convinced the Pfizer-Allergan Deal is a Go
By Stephen GandelNovember 23, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
FinanceWill the Pfizer Inversion Get It Booted From the Dow?
By Chris MatthewsNovember 23, 2015
Pfizer In Merger Talks With Allergan PLC
FinancePfizer/Allergan deal pushes 2015 into the record books
By Dan PrimackNovember 23, 2015
Prediction: Healthcare’s M&A Flood Will Ebb in 2016
HealthPrediction: Healthcare’s M&A Flood Will Ebb in 2016
By Jen WiecznerNovember 23, 2015
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
FinanceWhy New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By Stephen GandelNovember 20, 2015
Pfizer In Merger Talks With Allergan PLC
LeadershipWill Lobbying Dollars Put Pfizer and Allergan On The Fast Track?
By Paul HodgsonNovember 20, 2015
Pfizer employees inside of a laboratory at Pfizer's research and development facility in Cambridge, Massachusetts, U.S., on Monday, Oct. 26, 2015. Photographer: Scott Eisen/Bloomberg *** Local Caption ***
FinanceWhy Pfizer Is Headed for Splitsville After Allergan Merger
By Jen WiecznerNovember 19, 2015
1...
  • 33
  • 34
  • 35
  • 36
  • 37
38
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Ex-Google engineer says Larry Page, Sergey Brin and Sundar Pichai share the same trait—it's the lesson he swears by as a $7.2 billion AI CEOplaceholder alt text
By Orianna Rosa RoyleJune 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.